With a focus on improving access and modernizing surgical techniques, this episode covers how the hepatic artery infusion (HAI) pump is transforming the landscape for patients with liver-directed malignancies in Kentucky.

Host Dr. Zach Pulliam, Medical Oncology Fellow at University of Louisville, speaks with expert Dr. Michael Cavnar from the University of Kentucky Markey Cancer Center to discuss the history, clinical benefits, and new accessibility trials for HAI pump therapy.

The conversation focuses on the logistics of rural cancer care, survival benefits for colorectal liver metastases and cholangiocarcinoma, and the future of home-based chemotherapy infusion.

Host: Zach Pulliam, MD,

Guest: Michael Cavnar, MD

The Kentucky Society of Clinical Oncology (KYSCO)

blawrence@kysco-oncology.org

This episode explores the latest advancements in hepatic arterial infusion (HAI) pump therapy and its impact on cancer care in Kentucky. Surgical Oncologist Brent Xia, MD of the St. Elizabeth Cancer Center, discusses the multidisciplinary effort required to implement this technology and its role in providing targeted, high-dose chemotherapy for liver-directed

The conversation highlights the survival benefits of regional therapy, the importance of multidisciplinary tumor boards, and new ways to reduce financial toxicity for patients.

Host: Andrew Hearn, MD, Hematology & Oncology Fellow, University of Louisville

Guest: Brent Xia MD Surgical Oncologist, St. Elizabeth Healthcare / The Yung Family Cancer Center

The Kentucky Society of Clinical Oncology (KYSCO)

https://www.interaoncology.com/patients-caregivers/find-an-hai-center

blawrence@kysco-oncology.org

With a focus on improving access and managing toxicity, this episode covers how new therapies are transforming the landscape for small cell lung cancer patients across the state.

Host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, speaks with experts Dr. Goetz Kloecker and Dr. Firas Badin to discuss groundbreaking trials and treatment advances for small cell lung cancer like the IMforte and DeLLphi-304 studies. The conversation focuses on real-world implications, survival benefits, and the future of cancer care in Kentucky.

Host: Dr. Shreyas Kalantri

Guest: Dr. Goetz Kloecker

Guest: Dr. Firas Badin

The Kentucky Society of Clinical Oncology (KYSCO)

Email: blawrence@accc-cancer.org